SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001437749-16-037842
Filing Date
2016-08-19
Accepted
2016-08-19 16:05:18
Documents
5
Period of Report
2016-08-17
Items
Item 3.03: Material Modifications to Rights of Security Holders
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K dffn20160819_8k.htm 8-K 25646
2 EXHIBIT 3.1 ex3-1.htm EX-3.1 1926
3 exhibit3.jpg GRAPHIC 41074
4 exhibit2.jpg GRAPHIC 139397
5 exhibit1.jpg GRAPHIC 72608
  Complete submission text file 0001437749-16-037842.txt   378093
Mailing Address 2020 AVON COURT SUITE 4 CHARLOTTESVILLE VA 22902
Business Address 2020 AVON COURT SUITE 4 CHARLOTTESVILLE VA 22902 (434) 220-0718
Diffusion Pharmaceuticals Inc. (Filer) CIK: 0001053691 (see all company filings)

IRS No.: 300645032 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-24477 | Film No.: 161843247
SIC: 2834 Pharmaceutical Preparations